newsfilter
← Latest News
GlobeNewswire·

Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide

- Second human trial to be conducted as part of a long-term Master Service Agreement with MHI- Phase 1 study with Ceapro's pharmaceutical grade avenanthramide to be coordinated by MHI's Montreal Health Innovations Coordinating Center (MHICC) and led by D